NCT07401550 Assessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.
| NCT ID | NCT07401550 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University College Dublin |
| Condition | Cardiovascular Diseases (CVD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-12-09 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-12-09 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective, observational cohort study will evaluate the associations between wearable-derived biometrics and cardiovascular health, quantified by the American Heart Association's Life's Essential 8 framework, as well as related cardiovascular risk factors. The study aims to determine whether wearable biometrics can support the assessment of cardiovascular health and cardiovascular disease risk, both when used in isolation and in combination with point-of-care assessments.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years, or older * Internet access * Possession of a smartphone compatible with the Fitbit mobile app Exclusion Criteria: * Pregnancy * Unstable medical condition * Inability to provide informed consent * Mental or cognitive impairment precluding adherence to study protocol * Smartwatch cannot be worn, (e.g., allergic reactions), or cannot be worn in accordance with manufacturer guidelines (e.g., amputation, dark tattoos at wrist)
Contact & Investigator
Rory Lambe
PRINCIPAL INVESTIGATOR
University College Dublin
Frequently Asked Questions
Who can join the NCT07401550 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Diseases (CVD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07401550 currently recruiting?
Yes, NCT07401550 is actively recruiting participants. Contact the research team at rory.lambe@ucdconnect.ie for enrollment information.
Where is the NCT07401550 trial being conducted?
This trial is being conducted at Dublin, Ireland.
Who is sponsoring the NCT07401550 clinical trial?
NCT07401550 is sponsored by University College Dublin. The principal investigator is Rory Lambe at University College Dublin. The trial plans to enroll 100 participants.